Latest Breaking News On - Theralink assay - Page 1 : comparemela.com

Theralink® Acquires Exclusive Landmark Immunotherapy Patent including Biomarker from Vanderbilt University

/PRNewswire/ Theralink Technologies, Inc. (OTC: THER) ("Theralink" or the "Company"), a precision oncology company with a novel phosphoprotein and protein.

United statesMick ruxinEmanuel petricoinJustin balkoTheralink technologies incPrnewswire theralink technologies incVanderbilt university medical centerVanderbilt universityScience advisory boardAssociate professorTheralink assayPatent detailsTheralink technologiesReverse phase protein array

Telo Genomics Appoints Kris Weinberg as Chief Executive Officer

Telo Genomics Appoints Kris Weinberg as Chief Executive Officer
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

John meekisonHugh rogersGuardant healthMars centreGenomic healthAudit committeeNewsfile corpTechnology officerTelo genomics corpRegulation services providerVenture exchangeKris weinbergChief executive officerSherif louis phdChief technologyTelo genomics board director

Theralink® Technologies Accepted to Present Two Posters at the Upcoming San Antonio Breast Cancer Symposium

/PRNewswire/ Theralink Technologies (OTC: THER) ("Theralink" or the "Company"), a precision oncology company with a novel quantitative protein and.

United statesSan antonioMick ruxinTheralink technologies incProgram numberReverse phase protein arraySan antonio breast cancer symposiumTheralink technologiesTheralink assayAdvanced breast cancerPoster presentationNovel quantitativeDetermining dynamicPrecision therapySpecial sessionPhosphoprotein assay

Theralink® Acquires Two New Milestone Patents Relating to Methods for Treating Breast Cancer

/PRNewswire/ Theralink Technologies, Inc. (OTC: THER) ("Theralink" or the "Company"), a precision oncology company with a novel phosphoprotein-based assay.

United statesEmanuel petricoinMick ruxinGeorge mason universityTheralink technologies incPhase protein array technologyPredictive biomarker patentsBreast cancerTheralink technologiesScience advisory boardReverse phase protein array technologyTheralink assayPatent detailsTreating breast cancerReverse phase protein array